ARTICLE | Company News
Pfizer returns pain compounds to GLFD
March 30, 2004 8:00 AM UTC
PFE returned to Guilford (GLFD) rights to develop and commercialize NAALADase inhibitors. Under a May 2003 deal, PFE licensed exclusive rights to the class of compounds. The deal included a $5 million...